BACKGROUND: Previous studies identified worrying levels of sphygmomanometer inaccuracy and have not been repeated in the era of digital measurement of blood pressure. AIM: To establish the type and accuracy of sphygmomanometers in current use. DESIGN AND SETTING: Cross-sectional, observational study in 38 Oxfordshire primary care practices. METHOD: Sphygmomanometers were evaluated between 50 and 250 mmHg, using Omron PA350 or Scandmed 950831-2 pressure meters. RESULTS: Six hundred and four sphygmomanometers were identified: 323 digital (53%), 192 aneroid (32%), 79 mercury (13%), and 10 hybrid (2%) devices. Of these, 584 (97%) could be fully tested. Overall, 503/584 (86%) were within 3 mmHg of the reference, 77/584 (13%) had one or more error of 4-9 mmHg, and 4/584 (<1%) had one or more error of more than 10 mmHg. Mercury (71/75, 95%) and digital (272/308, 88%) devices were more likely to be within 3 mmHg of the reference standard than aneroid models (150/191, 78%) (Fisher's exact test P = 0.001). Donated aneroid devices from the pharmaceutical industry performed significantly worse: 10/23 (43%) within 3 mmHg of standard compared to 140/168 (83%) aneroid models from recognised manufacturers (Fisher's exact test P<0.001). No significant difference was found in performance between manufacturers within each device type, for either aneroid (Fisher's exact test P = 0.96) or digital (Fisher's exact test P = 0.7) devices. CONCLUSION: Digital sphygmomanometers have largely replaced mercury models in primary care and have equivalent accuracy. Aneroid devices have higher failure rates than other device types; this appears to be largely accounted for by models from indiscernible manufacturers. Given the availability of inexpensive and accurate digital models, GPs could consider replacing aneroid devices with digital equivalents, especially for home visiting.
BACKGROUND: Previous studies identified worrying levels of sphygmomanometer inaccuracy and have not been repeated in the era of digital measurement of blood pressure. AIM: To establish the type and accuracy of sphygmomanometers in current use. DESIGN AND SETTING: Cross-sectional, observational study in 38 Oxfordshire primary care practices. METHOD: Sphygmomanometers were evaluated between 50 and 250 mmHg, using Omron PA350 or Scandmed 950831-2 pressure meters. RESULTS: Six hundred and four sphygmomanometers were identified: 323 digital (53%), 192 aneroid (32%), 79 mercury (13%), and 10 hybrid (2%) devices. Of these, 584 (97%) could be fully tested. Overall, 503/584 (86%) were within 3 mmHg of the reference, 77/584 (13%) had one or more error of 4-9 mmHg, and 4/584 (<1%) had one or more error of more than 10 mmHg. Mercury (71/75, 95%) and digital (272/308, 88%) devices were more likely to be within 3 mmHg of the reference standard than aneroid models (150/191, 78%) (Fisher's exact test P = 0.001). Donated aneroid devices from the pharmaceutical industry performed significantly worse: 10/23 (43%) within 3 mmHg of standard compared to 140/168 (83%) aneroid models from recognised manufacturers (Fisher's exact test P<0.001). No significant difference was found in performance between manufacturers within each device type, for either aneroid (Fisher's exact test P = 0.96) or digital (Fisher's exact test P = 0.7) devices. CONCLUSION: Digital sphygmomanometers have largely replaced mercury models in primary care and have equivalent accuracy. Aneroid devices have higher failure rates than other device types; this appears to be largely accounted for by models from indiscernible manufacturers. Given the availability of inexpensive and accurate digital models, GPs could consider replacing aneroid devices with digital equivalents, especially for home visiting.
Authors: Eoin O'Brien; Thomas Pickering; Roland Asmar; Martin Myers; Gianfranco Parati; Jan Staessen; Thomas Mengden; Yutaka Imai; Bernard Waeber; Paolo Palatini; William Gerin Journal: Blood Press Monit Date: 2002-02 Impact factor: 1.444
Authors: Andrew J Coleman; Stephen D Steel; Mark Ashworth; Sarah L Vowler; Andrew Shennan Journal: Blood Press Monit Date: 2005-08 Impact factor: 1.444
Authors: Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He Journal: Lancet Date: 2005 Jan 15-21 Impact factor: 79.321
Authors: E O'Brien; J Petrie; W Littler; M de Swiet; P L Padfield; D G Altman; M Bland; A Coats; N Atkins Journal: J Hypertens Date: 1993-06 Impact factor: 4.844
Authors: Y Wan; C Heneghan; R Stevens; R J McManus; A Ward; R Perera; M Thompson; L Tarassenko; D Mant Journal: J Hum Hypertens Date: 2010-04-08 Impact factor: 3.012
Authors: James Hodgkinson; Constantinos Koshiaris; Una Martin; Jonathan Mant; Carl Heneghan; Fd Richard Hobbs; Richard J McManus Journal: Br J Gen Pract Date: 2016-03-29 Impact factor: 5.386
Authors: Evangelos Kontopantelis; David A Springate; David Reeves; Darren M Ashcroft; Martin K Rutter; Martin Rutter; Iain Buchan; Tim Doran Journal: Diabetologia Date: 2014-12-16 Impact factor: 10.122
Authors: James P Sheppard; Richard Stevens; Paramjit Gill; Una Martin; Marshall Godwin; Janet Hanley; Carl Heneghan; F D Richard Hobbs; Jonathan Mant; Brian McKinstry; Martin Myers; David Nunan; Alison Ward; Bryan Williams; Richard J McManus Journal: Hypertension Date: 2016-03-21 Impact factor: 10.190